Skip to content
clinical trial patient doctor clinical trial patient doctor

Achieve Late Phase Success with Precision

Navigate your late phase journey with efficiency and comprehensive solutions

Navigate complex Phase 2b-3 trials with scale and end-to-end solutions that propel your therapy towards market readiness. Precision for Medicine stands at the forefront of late phase clinical trials, offering scalability, full-service execution, and regulatory readiness to ensure your project's success.

 

Streamlining Success in Late Phase Trials

Strategic planning, patient recruitment, and operational efficiency are pillars of successful late-phase clinical trials. At Precision, we understand these challenges and offer a suite of services designed to optimize your trial’s performance from patient strategies to global operational execution.
  • Global CRO
  • Patient Strategies
  • Regulatory Approval
  • Precision Execution with Global Reach

    Leverage Precision's full-service outsourcing (FSO) or functional service provider (FSP) solutions to execute your late-phase trials with unmatched efficiency. Our global reach and integrated lab capabilities provide a one-stop solution, delivering consistency and quality across all study sites.

    Explore Global CRO
    Global Teams-Reach
  • Enhancing Trial Efficiency with Patient-Centric Approaches

    Discover how Precision emphasizes patient engagement and the capability to conduct decentralized clinical trials (DCTs), reducing patient burden and improving enrollment. Our strategies are tailored to meet the unique needs of late-phase trials, ensuring high participation rates and diverse participant representation.

    Explore DCT
    49. A middle-aged breast cancer woman hug and cuddle her daughter (1)
  • Navigating the Path to Market

    With strategic regulatory planning and in-depth expertise with FDA and EMA submissions, Precision navigates the complex regulatory landscape, ensuring your study is positioned for approval. Engage our regulatory strategists to streamline your path to market.

    Explore Regulatory Affairs
    ihc-patient

Oncology expertise by indication

Oncology Indication Experience_May24

Rare disease expertise by therapeutic area

Rare Disease Expertise_May 24

Broadening Horizons in Late Phase Trials

As you approach the pivotal late stages of clinical development, Precision for Medicine stands ready with a comprehensive suite of augmentative services. These services are meticulously designed to not only support trial execution but also ensure seamless transition to commercialization, amplifying the impact of your therapeutic innovations.
  • Lab Services
  • Precision Technologies
  • Manufacturing Solutions
  • IVD & CDX Regulatory
  • Precision Integrated Labs

    In the realm of late-phase development, the nuanced role of biomarkers becomes increasingly pivotal. Precision’s specialty and central lab services adeptly handle biomarker analysis, patient stratification, and safety monitoring, delivering the high-quality, actionable data essential for late-phase trials. Dive deeper into how our lab solutions can propel your therapy’s late-stage success.

    Explore Precision’s Labs
    WS Lab-1
  • Harnessing Technology for Insightful Breakthroughs

    Embrace the cutting-edge with Precision Technologies, where tools like Apostream, EpiontisID, and QuartzBio’s Biomarker Data Management redefine the scope of trial insights. With Virtual Sample Management and MetaVate, our technologies offer unparalleled depth to your data analysis, propelling your therapy’s journey with evidence-backed precision.

    Explore Precision 360 Intelligence
    Risk Based Monitoring RBM
  • Navigating to Commercial Readiness

    As your therapy edges closer to commercialization, the complexities of manufacturing demand a strategic approach. Precision’s Manufacturing Solutions, specializing in advanced therapies, ensure your journey from clinical scale to market readiness is both scalable and compliant, setting the stage for your therapeutic innovation’s successful launch.

    Explore Manufacturing
    Drug-Cell Manufacturing
  • Regulatory Mastery for IVD & CDx

    With a century’s worth of combined expertise, Precision for Medicine’s IVD Regulatory Team offers unparalleled guidance for IVDs and Companion Diagnostics. Across continents and regulatory landscapes, we craft strategies that streamline global assay testing and registrations, ensuring your diagnostics meet global standards and accelerate your therapy's market entry.

    Explore IVD & CDX
    IVD CDx development

Precision late phase resources

Discover our collection of resources designed to optimize and accelerate your late phase development.

View all resources
  • Expanding your therapy's impact with Precision

    Beyond clinical trials, Precision for Medicine extends your reach into health economics, market access, and medical communications to ensure your therapy achieves its fullest potential and commercial success.

     

  • HEOR Strategy and Evidence

    HEOR Strategy & Evidence

    Shaping Value with HEOR

    Deploy Precision's HEOR expertise early to articulate your therapy's value, preparing for successful market access. We integrate economic and clinical insights to craft compelling narratives for payers and regulators.

  • GettyImages-906006644-Doctor_Talking-to_Patient-RET

    Market Access Planning

    Navigating Market Access Landscapes

    Our strategic market access plans position your therapy for optimal reimbursement and adoption. Precision's insights into payer landscapes guide your product through to commercial viability.

  • HCP and Engagement

    HCP & Engagement

    Medical Communications for Adoption

    Utilize our medical communications expertise to foster therapy awareness and adoption. Precision balances clinical benefits with humanistic elements, enhancing therapeutic choice and market penetration.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore

Navigating late phase with Precision insights

Stay informed with the latest late phase and clinical trial insights from our experts, who share knowledge, trends, and success stories from the forefront of clinical research.

Read: Advancing Diversity in Oncology Clinical Trials: 5 Key Insights from Clinical Trial Sites Advancing Diversity in Oncology Clinical Trials: 5 Key Insights from Clinical Trial Sites

Clinical Trials

Advancing Diversity in Oncology Clinical Trials: 5 Key Insights from Clinical Trial Sites

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=184750975030, hs_child_table_id=0, hs_updated_at=1736962069119, hs_published_at=1736962071401, description=Melanie Morris brings over two decades of experience in pivotal roles supporting Phase I to IV clinical trials within Site, CRO and Sponsor organizations. As Associate Director of the Precision Site Network at Precision for Medicine, Melanie is dedicated to fostering collaborative, mutually beneficial partnerships with clinical research sites, transforming transactional relationships into enduring alliances that drive shared success. With a career spanning leadership in clinical operations, functional service provider models, and decentralized trial execution, Melanie has consistently delivered innovative strategies that enhance site engagement and operational excellence. Passionate about creating impactful collaborations, Melanie aims to advance the clinical research landscape and support the development and acceleration of life-changing rare disease and oncology therapies., avatar=Image{width=1218,height=1218,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Melanie%20Morris.jpg',altText='Melanie Morris',fileId=184761298465}, lastname=Morris, hs_initial_published_at=1736540185270, hs_created_by_user_id=26433386, hs_created_at=1736527212397, hs_is_edited=false, hs_deleted_at=0, name=Melanie, job=Associate Director, Precision Site Network, slug=melanie-morris, hs_updated_by_user_id=26433386}, second={hs_id=178046423372, hs_child_table_id=0, hs_updated_at=1725972626778, hs_published_at=1736962071401, description=Rosamund (Roz) Round is a seasoned expert in patient engagement and innovation bringing over 20 years of experience. She is focused on listening to and learning from patients and care partners to understand how to better improve trial access and experience. Roz successfully built and led decentralized clinical trials service through the pandemic and is now addressing the implementation of AI across various aspects of clinical research. She has a strong focus on diversity, equity, and inclusion (DEI) to drive health equity in clinical research. Roz holds an MSc in Health Psychology, studied Psychology and Immunology at Harvard University, and is a recognized thought leader with an extensive portfolio of publications, conference presentations, webinars, and vlogs., avatar=Image{width=600,height=600,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Round%20Rosamund.jpg',altText='Round Rosamund',fileId=177993009992}, lastname=Round, hs_initial_published_at=1725972637852, hs_created_by_user_id=51739740, hs_created_at=1725972446462, hs_is_edited=false, hs_deleted_at=0, name=Rosamund, job=Vice President, PAtient Engagement & Innovation, slug=rosamund-round, hs_updated_by_user_id=51739740}, third={}})
  • Melanie M. avatar

    Melanie M.

  • Rosamund R. avatar

    Rosamund R.

Discover
Read: Top Functional Service Providers (FSPs) in Clinical Research for 2025 Top Functional Service Providers (FSPs) in Clinical Research for 2025

Clinical Trials

Top Functional Service Providers (FSPs) in Clinical Research for 2025

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1736540179119, hs_published_at=1736962071401, description=Rob Maiale is an innovative marketing leader and creative technologist who transforms complex healthcare challenges into meaningful, impactful stories. With over 15 years of experience across clinical and translational research, patient education, pharmaceuticals, and diagnostics, he merges cutting-edge technology with inspired storytelling to build award-winning brand narratives. At Precision, Rob collaborates with leading experts to translate deep scientific expertise into accessible, engaging, and culturally resonant content—connecting audiences to the future of life-changing research., avatar=Image{width=400,height=400,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rob%20Maiale.jpg',altText='Rob Maiale',fileId=184765575245}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1729783715853, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, job=, slug=rob-maiale, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover
Read: Clinical Trial Trends: Non-malignant Hematology Clinical Trial Trends: Non-malignant Hematology

Clinical Trials

Clinical Trial Trends: Non-malignant Hematology

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=176359181458, hs_child_table_id=0, hs_updated_at=1724336086523, hs_published_at=1736962071401, description=Jen Vance is a Senior Director of Operational Strategy at Precision whose career spans over twenty years within the CRO industry. She has provided portfolio and departmental oversight, clinical development planning, therapeutic strategy and provision of therapeutic expertise. Jen has vetted drug development experience in phase I through IV hematology / oncology studies, with a specialized focus on hematologic malignancies, targeted therapies and immunotherapies. , avatar=Image{width=557,height=554,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Jen%20Vance.jpg',altText='Jen Vance',fileId=176365370249}, lastname=Vance, hs_initial_published_at=1724336101839, hs_created_by_user_id=51739740, hs_created_at=1724336037903, hs_is_edited=false, hs_deleted_at=0, name=Jen, job=Senior Director of Operational Strategy, slug=jen-vance, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Jen Vance avatar

    Jen Vance

Discover

Pioneer new therapies with Precision expertise

With Precision, your pioneering treatments in Oncology, Rare Diseases, and beyond are propelled from concept to reality, supported by teams with deep domain expertise and innovative approaches.